Growth Metrics

Standard Biotools (LAB) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 Standard Biotools 448.37 Mn -6.80 Mn 11.31 Mn 43.82%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43.82%
Dec 31, 2025 0.19%
Sep 30, 2025 -17.62%
Jun 30, 2025 26.81%
Mar 31, 2025 19.04%
Dec 31, 2024 170.16%
Sep 30, 2024 -28.29%
Jun 30, 2024 -168.30%
Mar 31, 2024 -90.92%
Dec 31, 2023 5.13%
Sep 30, 2023 28.64%
Jun 30, 2023 73.18%
Mar 31, 2023 77.92%
Sep 30, 2022 -112.57%
Jun 30, 2022 -270.64%
Mar 31, 2022 -305.33%
Sep 30, 2021 -130.76%
Jun 30, 2021 -31.72%
Mar 31, 2021 -17.78%
Dec 31, 2020 -42.10%
Sep 30, 2020 53.45%
Jun 30, 2020 5.37%
Mar 31, 2020 37.25%
Dec 31, 2019 14.15%
Sep 30, 2019 12.63%
Jun 30, 2019 15.32%
Mar 31, 2019 -92.23%
Dec 31, 2018 -41.29%
Sep 30, 2018 7.49%
Jun 30, 2018 4.09%
Mar 31, 2018 22.99%
Dec 31, 2017 40.91%
Sep 30, 2017 19.43%
Jun 30, 2017 9.05%
Mar 31, 2017 13.49%
Dec 31, 2016 -37.40%
Sep 30, 2016 -113.50%
Jun 30, 2016 -22.19%
Mar 31, 2016 -24.81%
Dec 31, 2015 -17.68%
Sep 30, 2015 32.78%
Jun 30, 2015 -20.14%
Mar 31, 2015 -3.35%
Dec 31, 2014 -135.71%
Sep 30, 2014 -221.75%
Jun 30, 2014 -213.45%
Mar 31, 2014 -334.07%
Dec 31, 2013 -28.90%
Sep 30, 2013 -3.23%
Jun 30, 2013 11.66%
Mar 31, 2013 46.92%
Dec 31, 2012 -4.19%
Sep 30, 2012 7.51%
Jun 30, 2012 36.26%
Mar 31, 2012 8.83%
Dec 31, 2011 -12.31%
Sep 30, 2011 -32.81%
Jun 30, 2011 -49.12%